Similarly, it has shown that DNA vaccine against FAP in the CT26 mouse colon cancer model promoted anti-tumor immune responses by increasing the infiltration of CD8+ T cells and tumor lymphocytes into TME, decreasing the expression levels of collagen in TME, and prolonging survival. Here, FAP is linked to malignant colon neoplasm.